Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Inventory (2022 - 2025)

Immunocore Holdings' Inventory history spans 4 years, with the latest figure at $6.7 million for Q4 2025.

  • For Q4 2025, Inventory rose 23.8% year-over-year to $6.7 million; the TTM value through Dec 2025 reached $6.7 million, up 23.8%, while the annual FY2025 figure was $6.7 million, 23.8% up from the prior year.
  • Inventory for Q4 2025 was $6.7 million at Immunocore Holdings, up from $5.7 million in the prior quarter.
  • Across five years, Inventory topped out at $6.8 million in Q1 2025 and bottomed at $692000.0 in Q4 2022.
  • The 4-year median for Inventory is $5.0 million (2024), against an average of $4.7 million.
  • The largest annual shift saw Inventory skyrocketed 550.43% in 2023 before it grew 21.0% in 2024.
  • A 4-year view of Inventory shows it stood at $692000.0 in 2022, then surged by 550.43% to $4.5 million in 2023, then rose by 21.0% to $5.4 million in 2024, then grew by 23.8% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for IMCR's Inventory are $6.7 million (Q4 2025), $5.7 million (Q3 2025), and $5.5 million (Q2 2025).